A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study

Clinical trial NCT05777993 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05777993
Sponsor: Agios Pharmaceuticals, Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 4
Study type: INTERVENTIONAL

Pyruvate Kinase Deficiency Anemia, Hemolytic Sickle Cell Disease Thalassemia

Start date: 2023-07-06
Primary completion: 2029-08-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.